HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Herbalife Relaunches To ‘2.0’ With 'Unified, Global Platform' After Sales Fall 10.3% In 2022

Executive Summary

Direct seller announces relaunch after year-long sales slump blamed on macroeconomic inflationary pressures. No full-year guidance due to rapidly shifting macroeconomic environment and increased market volatility.

You may also be interested in...



Herbalife Sees ‘Saturation’ In Price Increases, Potential Marketing To Weight Loss Drug Patients

Wellness, nutrition and weight loss direct seller announces it’s launching vegan product line in US and is considering a nutrition and lifestyle program its distributors could offer to consumers prescribed drugs for diabetes management and weight loss. 

Following 6.3% Q1 Sales Slump, Herbalife Expects To Ride North America To Turnaround

Direct seller declines to provide guidance due to dynamic macroeconomic environment but expects a return to growth by end of year led by North America.

Herbalife Fuels ‘2.0’ Relaunch With Survey: 40% Of US Consumers Have Some Sort Of Second Job

Survey it commissioned shows 40% of US consumers turning to “side hustles” such as selling products for MLMs. Firm also launched 106 SKUs during the January-March period and has hired former Fiat Chrysler Automobiles exec as investors relations VP.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153396

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel